Your browser doesn't support javascript.
loading
Microbiological Characteristics and Antibiotic Sensitivity in Patients with Nosocomial Spontaneous Bacterial Peritonitis Caused by Escherichia coli: A Multicenter Study.
Tu, Bo; Zhang, Yuening; Bi, Jingfeng; Xu, Zhe; Shi, Lei; Zhang, Xin; Zhao, Peng; Zhang, Dawei; Yang, Guang; Qin, Enqiang.
Afiliação
  • Tu B; Department of Infectious disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhang Y; Bo Tu, Yuening Zhang, and Jingfeng Bi contributed equally to this work.
  • Bi J; Center of Hepatology and Gastroenterology, Beijing Capital Medical University You'an Hospital, China.
  • Xu Z; Bo Tu, Yuening Zhang, and Jingfeng Bi contributed equally to this work.
  • Shi L; Department of Clinical and Translational Medicine, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhang X; Bo Tu, Yuening Zhang, and Jingfeng Bi contributed equally to this work.
  • Zhao P; Department of Infectious disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhang D; Department of Infectious disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yang G; Department of Infectious disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Qin E; Department of Infectious disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Infect Microbes Dis ; 2(4): 167-172, 2020 Dec.
Article em En | MEDLINE | ID: mdl-38630105
ABSTRACT
Escherichia coli is a prevalent causative pathogen of spontaneous bacterial peritonitis (SBP). In this retrospective study, we investigated the microbiological characteristics and antibiotic susceptibility of E. coli clinical isolates obtained from liver cirrhosis patients suffering from nosocomial SBP. Our results showed that extended-spectrum ß-lactamase (ESBL)-producing E. coli accounted for 47% of the cases, while 62% of the isolates were multi-drug resistant (MDR) pathogens. ESBL-producing and MDR isolates showed high incidences of resistance to third-generation cephalosporins, but they displayed susceptibility to carbapenems, ß-lactamase inhibitors, and aminoglycosides. Importantly, liver cirrhosis patients with MDR E. coli SBP showed a significantly higher death rate than patients with non-MDR infections (P = 0.021). The 30-day mortality of nosocomial SBP was independently correlated with female gender [odds ratio (OR) = 5.200, 95% confidence interval (CI) = 1.194-22.642], liver failure (OR = 9.609, 95% CI = 1.914-48.225), hepatocellular carcinoma (OR = 8.176, 95% CI = 2.065-32.364), hepatic encephalopathy (OR = 8.176, 95% CI = 2.065-32.364), model of end-stage liver disease score (OR = 1.191, 95% CI = 1.053-1.346), white blood cell count (OR = 0.847, 95% CI = 0.737-0.973), and ascites polymorphonuclear (OR = 95.903, 95% CI = 3.410-2697.356). In conclusion, third-generation cephalosporins may be inappropriate for empiric treatment of nosocomial SBP caused by E. coli, due to the widespread presence of ESBLs and high incidence of MDR pathogens.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Microbes Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Microbes Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China